← Leaderboards
Tia H. Turner
Virginia Commonwealth University
$114,555
Attributed
$114,555
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $38.7K · FY2019–21$50K$37.5K$25K$12.5K$0
'19
'20
'21
Funding mix
By agency
NIH$114,555 · 1
By mechanism
F30$114,555 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Joshua (chuck) Harrell$3,090,169
- Joseph William Landry$2,951,878
- David Paul Turner$4,247,919
- Victoria Jane Findlay$1,621,859
- Phillip B Hylemon$8,797,545
Others in their field
Other Emerging Leaders on “Androgen Receptor”
- Himisha Beltran · Dana-Farber Cancer Inst$7,515,798
- Aaron Matthew Lebeau · University Of Wisconsin-Madison$5,223,811
- Li Jia · Brigham And Women'S Hospital$4,130,520
- Harshini Neelakantan · Ridgeline Therapeutics, Llc$3,718,852
- Felix Yi-Chung Feng · University Of California, San Francisco$3,606,761
- Andrew J Armstrong · Duke University$3,558,683
Research focus
Androgen ReceptorAutomobile DrivingBaseBlood - Brain Barrier AnatomyBrainBreast Cancer CellBreast Cancer Cell LineBreast Cancer PatientCancer Gene ExpressionCastrationCategoriesCell LineCellsCell SurvivalCessation Of LifeChemotherapyClinically RelevantClinical ResearchCombined Modality TherapyCytotoxicData SetDiagnosisDisease ProgressionAdvanced Disease
Grant awards (3)
Development of novel combination treatments for metastatic androgen receptor-positive triple-negative breast cancer$38,697
F30 · FY2021 · CA · contact PI
Development of novel combination treatments for metastatic androgen receptor-positive triple-negative breast cancer$38,181
F30 · FY2020 · CA · contact PI
Development of novel combination treatments for metastatic androgen receptor-positive triple-negative breast cancer$37,677
F30 · FY2019 · CA · contact PI